163 related articles for article (PubMed ID: 19671594)
1. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?
Torras J; Herrero-Fresneda I; Gulias O; Flaquer M; Vidal A; Cruzado JM; Lloberas N; Franquesa Ml; Grinyó JM
Nephrol Dial Transplant; 2009 Dec; 24(12):3632-40. PubMed ID: 19671594
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
[TBL] [Abstract][Full Text] [Related]
4. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
5. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
[TBL] [Abstract][Full Text] [Related]
6. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
7. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
8. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
[TBL] [Abstract][Full Text] [Related]
9. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.
Diekmann F; Rovira J; Carreras J; Arellano EM; Bañón-Maneus E; Ramírez-Bajo MJ; Gutiérrez-Dalmau A; Brunet M; Campistol JM
J Am Soc Nephrol; 2007 Oct; 18(10):2653-60. PubMed ID: 17804674
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice.
Stylianou K; Petrakis I; Mavroeidi V; Stratakis S; Kokologiannakis G; Lioudaki E; Liotsi C; Kroustalakis N; Vardaki E; Stratigis S; Perakis K; Kyriazis J; Nakopoulou L; Daphnis E
Nephrol Dial Transplant; 2012 Aug; 27(8):3141-8. PubMed ID: 22290989
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
13. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
14. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.
Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J
J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
Ko HT; Yin JL; Wyburn K; Wu H; Eris JM; Hambly BD; Chadban SJ
Nephrol Dial Transplant; 2013 Feb; 28(2):327-36. PubMed ID: 23229928
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.
Rovira J; Arellano EM; Carreras J; Campos B; Vodenik B; Bañón-Maneus E; Ramírez-Bajo MJ; Moya-Rull D; Solé-González A; Hernández A; Revuelta I; Quintana LF; Howat WJ; Campistol JM; Diekmann F
Transplantation; 2009 Sep; 88(5):646-52. PubMed ID: 19741461
[TBL] [Abstract][Full Text] [Related]
17. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
Matsui I; Hamano T; Tomida K; Inoue K; Takabatake Y; Nagasawa Y; Kawada N; Ito T; Kawachi H; Rakugi H; Imai E; Isaka Y
Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
[TBL] [Abstract][Full Text] [Related]
19. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
Ruiz JC; Campistol JM; Sánchez-Fructuoso A; Rivera C; Oliver J; Ramos D; Campos B; Arias M; Diekmann F
Nephrol Dial Transplant; 2006 Nov; 21(11):3252-7. PubMed ID: 16954170
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
